Document 0395
 DOCN  M9650395
 TI    [Frequency and mode of use of testing for HIV infection in women
       hospitalized for childbirth]
 DT    9605
 AU    Puro V; Romano S; De Santis MT; Aloisi MS; D'Ubaldo C; Girardi E;
       Ippolito G; Centro di Riferimento AIDS, Ospedale L. Spallanzani, Roma.
 SO    Minerva Ginecol. 1995 Oct;47(10):439-45. Unique Identifier : AIDSLINE
       MED/96158251
 AB    OBJECTIVE: To assess the use of HIV testing because of pregnancy.
       DESIGN: Cross-sectional study. PATIENTS: Parturients admitted to the
       obstetric divisions of a public hospital located in Rome (February-April
       1994). INTERVENTION: Standardized interview during post test counseling.
       OUT-COMES: Frequency and characteristics of HIV testing because of
       pregnancy and women's know ledge on HIV sexual and vertical
       transmission. RESULTS: Among the 506 women admitted all consented to be
       tested and 3 were found HIV seropositive (0.6%). A total of 239 (47%)
       unselected parturients were interviewed; the remaining differ only for a
       lower rate of cesarean delivery (13% vs 54%). Of the interviewed, 140
       (58%) had been already tested for HIV infection, 91 (38%) during the
       current pregnancy according to gynaecologist's prescription (79.87%) and
       without counseling (55.60%) or ascertained risk factors (82.90%); 40%
       had been tested after the first trimester of pregnancy. Rate of vertical
       transmission was estimated higher than 50% in 147 cases; 150 women knew
       the window period but less than half estimated it correctly.
       CONCLUSIONS: The study showed a unsatisfactory use of HIV testing
       because of pregnancy and suggests the need for implementing in Italy
       information campaigns targeted both to women and gynecologists.
 DE    Adult  Cross-Sectional Studies  English Abstract  Female  Hospitals,
       Maternity  Human  HIV Infections/*DIAGNOSIS/DRUG THERAPY/TRANSMISSION
       HIV Seropositivity/*EPIDEMIOLOGY  Pregnancy  Pregnancy Complications,
       Infectious/*DIAGNOSIS/DRUG THERAPY/  VIROLOGY  Rome/EPIDEMIOLOGY
       Support, Non-U.S. Gov't  Zidovudine/*THERAPEUTIC USE  JOURNAL ARTICLE

       SOURCE: National Library of Medicine.  NOTICE: This material may be
       protected by Copyright Law (Title 17, U.S.Code).